You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Sherlock Holmes Mystery Magazine returns after a brief hiatus with a selection of fiction and nonfiction for the discerning mystery reader. This issue's stories include: LH’s LEGACY, by Rochelle Campbell ROOKER, by Laird Long PENNWOOD AVENUE, by Sanford Zane Meschkow ABOVE SUSPICION, by Victoria Weisfeld IDYLLWILD, by Michael Hemmingson MOTIVE, by Marc Bilgrey THE CURIOUS CASE OF ARTHUR CONAN DOYLE, by Gary Lovisi THE DAYTIME SERIAL KILLER, by Dan Andriacco THE MYSTERY OF THE PAUL HENRY, by Michael Penncavage THE PROBLEM OF THE VANISHING BULLET, by Lee Enderlin THE ADVENTURE OF THE BERYL CORONET, by Sir Arthur Conan Doyle Nonfiction includes: THREE BUCKET MYSTERIES, by Eugene D. Goodwin THREE CHEERS FOR DR WATSON, by Janice Law
The past several decades have been a time of rapid globalization in the development, manufacture, marketing, and distribution of medical products and technologies. Increasingly, research on the safety and effectiveness of new drugs is being conducted in countries with little experience in regulation of medical product development. Demand has been increasing for globally harmonized, science-based standards for the development and evaluation of the safety, quality, and efficacy of medical products. Consistency of such standards could improve the efficiency and clarity of the drug development and evaluation process and, ultimately, promote and enhance product quality and the public health. To explore the need and prospects for greater international regulatory harmonization for drug development, the IOM Forum on Drug Discovery, Development, and Translation hosted a workshop on February 13-14, 2013. Discussions at the workshop helped identify principles, potential approaches, and strategies to advance the development or evolution of more harmonized regulatory standards. This document summarizes the workshop.
Clinical trials provide essential information needed to turn basic medical research findings into patient treatments. New treatments must be studied in large numbers of humans to find out whether they are effective and to assess any harm that may arise from treatment. There is growing recognition among many stakeholders that the U.S. clinical trials enterprise is unable to keep pace with the national demand for research results. The IOM, along with the Mount Sinai School of Medicine, held a workshop June 27-28, 2011, to engage stakeholders and experts in a discussion about possible solutions to improve public engagement in clinical trials.
Individuals with disabilities, chronic conditions, and functional impairments need a range of services and supports to keep living independently. However, there often is not a strong link between medical care provided in the home and the necessary social services and supports for independent living. Home health agencies and others are rising to the challenges of meeting the needs and demands of these populations to stay at home by exploring alternative models of care and payment approaches, the best use of their workforces, and technologies that can enhance independent living. All of these challenges and opportunities lead to the consideration of how home health care fits into the future hea...
Welcome to Black Cat Weekly #43. If this isn’t the best issue we had to date, it’s pretty darn close. Lots of great tales are packed into this one—including not one, but two mystery novels (by Edwin Balmer and Nicholas Carter), three shorter mysteries (including a major new novelet by Robert Lopresti, a great reprint by Victoria Weisfeld, and a solve-it-yourself puzzler from Hal Charles). On the science fiction side, we have an amazing set of stories by Daniel Marcus, Isaac Asimov, George O. Smith, Murray Leinster, and Robert Silverberg. It’s hard to get better than that. Oh, wait—we also have an interview with Robert Varley, courtesy of Darrell Schweitzer. This is another one of h...
This report analyses the present system of identifying and testing medical technologies and of synthesizing and disseminating assess- ment information. The report focuses on the flow of information that is central to an efficient assessment system. Methods for te- sting technologies and for synthesizing information are explored, and a compendium of data and bibliographic sources are included. The re- port also describes the innovation process for medical technologies, the effects that federal policies have on that process, and the needs those policies generate for technology assessment information. It critiques the current system of assessment and provides policy options, both legislative and oversight, for congress to improve the system.
The research ethics system was created without the help of people who know what it is like to be a research subject. This is a serious omission. Experts have overlooked ethical issues that matter to subjects. Silent Partners moves subjects to the forefront, giving them a voice in research ethics.
This text provides an introductory perspective of evidence-based practice in nursing and healthcare. The need for explicit and judicious use of current best evidence in making decisions about the care of individual patients leads the list of the goals of today’s healthcare leader. The Second Edition of this best-selling text has been completely revised and updated and contains new chapters on Evidence-based Regulation and Evidence and Innovation.